- CA$31.86m
- CA$183.28m
- $140.64m
- 33
- 86
- 26
- 46
Annual income statement for Ionik, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 15 M | 12 M |
Source: | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 18 | 17.1 | 114 | 141 |
Cost of Revenue | ||||
Gross Profit | 10.4 | 10.8 | 46.5 | 55.5 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Total Operating Expenses | 19.3 | 19 | 130 | 188 |
Operating Profit | -1.26 | -1.91 | -15.6 | -47 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -6.23 | 1.69 | -19.2 | -56.5 |
Provision for Income Taxes | ||||
Net Income After Taxes | -6.3 | 1.59 | -19.3 | -56.2 |
Net Income Before Extraordinary Items | ||||
Extraordinary Items | ||||
Net Income | -6.3 | 1.59 | -23.9 | -63.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -6.3 | 1.59 | -23.9 | -63.1 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.118 | 0.022 | -0.038 | -0.091 |
Dividends per Share |